The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline
Alzheimer's & Dementia · 2024-01 · 20 (1) · 221-233
DOI: 10.1002/alz.13355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 09.08.2023. Verfasst von Cecilia Boccalini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, G…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
INTRODUCTION Tau and neurodegeneration strongly correlate with cognitive impairment, as compared to amyloid. However, their contribution in explaining cognition and predicting cognitive decline in memory clinics remains unclarified. METHODS We included 94 participants with Mini‐Mental State Examination (MMSE), tau positron emission tomography (PET), amyloid PET, fluorodeoxyglucose (FDG) PET, and MRI scans from Geneva Memory Center. Linear regression and mediation analyses tested the independent and combined association between biomarkers, cognitive performance, and decline. Linear mixed‐effects and Cox proportional hazards models assessed biomarkers’ prognostic values. RESULTS Metabolism had the strongest association with cognition (r = 0.712; p < 0.001), followed by tau (r = ‐0.682; p < 0.001). Neocortical tau showed the strongest association with cognitive decline (r = ‐0.677; p < 0.001). Metabolism mediated the association between tau and cognition and marginally mediated the one with decline. Tau positivity represented the strongest risk factor for decline (hazard ratio = 32). DISCUSSION Tau and neurodegeneration synergistically contribute to global cognitive impairment while tau drives decline. The tau PET superior prognostic value supports its implementation in memory clinics. Highlights Hypometabolism has the strongest association with concurrent cognitive impairment. Neocortical tau pathology is the main determinant of cognitive decline over time. FDG‐PET has a superior value compared to MRI as a measure of neurodegeneration. The prognostic value of tau‐PET exceeded all other neuroimaging modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Vita-Salute San Raffaele University, Milan, Italy.
- In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Geneva Memory Center, Geneva University Hospitals, Geneva, Switzerland.
- Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
- Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Zitieren
APA
Boccalini, C., Ribaldi, F., Hristovska, I., Arnone, A., Peretti, D. E., Mu, L., Scheffler, M., Perani, D., Frisoni, G. B., & Garibotto, V. (2024). The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimer's & Dementia, 20(1), 221-233. https://doi.org/10.1002/alz.13355
Vancouver
Boccalini C, Ribaldi F, Hristovska I, Arnone A, Peretti DE, Mu L, et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimer's & Dementia. 2024;20(1):221-233. doi:10.1002/alz.13355
BibTeX
@article{Boccalini2024,
author = {Boccalini, Cecilia and Ribaldi, Federica and Hristovska, Ines and Arnone, Annachiara and Peretti, Débora Elisa and Mu, Linjing and Scheffler, Max and Perani, Daniela and Frisoni, Giovanni B and Garibotto, Valentina},
title = {The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {1},
pages = {221--233},
doi = {10.1002/alz.13355}
}
EUVIMED